NuVasive Inc
NASDAQ:NUVA
NuVasive Inc
Revenue
NuVasive Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NuVasive Inc
NASDAQ:NUVA
|
Revenue
$1.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
NuVasive Inc
Revenue Breakdown
Breakdown by Geography
NuVasive Inc
Total Revenue:
1.2B
USD
|
United States:
925.9m
USD
|
Non-Us:
276.1m
USD
|
Breakdown by Segments
NuVasive Inc
Total Revenue:
1.2B
USD
|
Products:
1.1B
USD
|
Spinal Hardware:
909.8m
USD
|
Surgical Support:
292.2m
USD
|
Services:
111m
USD
|
See Also
What is NuVasive Inc's Revenue?
Revenue
1.2B
USD
Based on the financial report for Jun 30, 2023, NuVasive Inc's Revenue amounts to 1.2B USD.
What is NuVasive Inc's Revenue growth rate?
Revenue CAGR 10Y
7%
Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for NuVasive Inc have been 5% over the past three years , 3% over the past five years , and 7% over the past ten years .